What is KMTS stock price today?

KMTS (Kestra Medical Technologies Ltd) stock is trading at $19.97 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is KMTS stock going up or down today?

KMTS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy KMTS stock now?

The decision to buy KMTS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is KMTS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for KMTS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is KMTS stock overvalued or undervalued?

Use our DCF valuation calculator to determine if KMTS is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is KMTS's P/E ratio?

P/E ratio data for KMTS will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is KMTS's market cap?

KMTS (Kestra Medical Technologies Ltd) has a market capitalization of $1.10 billion, making it a small-cap stock.

What is KMTS's price to book ratio?

KMTS trades at a price-to-book (P/B) ratio of 3.62, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does KMTS pay dividends?

KMTS does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is KMTS's dividend yield?

KMTS does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is KMTS stock a good long-term investment?

KMTS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is KMTS's revenue growth rate?

KMTS has shown revenue growth of 0.6% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

KMTS is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in KMTS?

Key risks for KMTS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does KMTS compare to its competitors?

Compare KMTS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize KMTS's performance and positioning.

What is KMTS's stock price target for 2026?

Our AI model provides price targets for KMTS based on fundamental analysis: Bull case $25.96 (+30%), Base case $22.97 (+15%), Bear case $17.97 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about KMTS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for KMTS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is KMTS's next earnings report?

KMTS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

KMTS - Kestra Medical Technologies Ltd

NYSE * Health Care * Health Care Equipment & Supplies

$19.97

+$0.23 (+1.17%)

About Kestra Medical Technologies Ltd

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

KMTS Key Statistics

Market Cap

$1.10B

P/B Ratio

3.62

EPS

$-5.73

Revenue Growth

+0.6%

Profit Margin

-1.7%

Employees

330

How KMTS Compares to Peers

KMTS has the fastest revenue growth among competitors

KMTS is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
KMTS(This stock)	$1.10B	N/A	1%	-1.7%	-
AMZNAmazon Com	$2.68T	34.7	0%	0.1%	vs AMZN

Kestra Medical Technologies Ltd Company Information

Headquarters: Washington; U.S.A
Website: kestramedical.com
Sector: Health Care
Industry: Health Care Equipment & Supplies

KMTS - Kestra Medical Technologies Ltd

About Kestra Medical Technologies Ltd

KMTS Key Statistics

How KMTS Compares to Peers

Kestra Medical Technologies Ltd Company Information

KMTS Lician Score

KMTS Financial Snowflake

Upcoming Events for KMTS